Stream Biomedical

Stream Biomedical is a product development company focused on developing neuroprotective and neurorestorative therapies. Stream holds the global exclusive license for intellectual property related to the therapeutic use of biologics for treating stroke, traumatic brain injury, spinal cord injury, Alzheimer’s disease, vascular dementia, Parkinson’s disease, and other neurological disorders. Stream Biomedical is commercializing a therapeutic protein that has demonstrated significant neuroprotective and neurorestorative effects, markedly improving function when administered after neural injury. The initial targeted therapeutic application is the treatment of acute stroke, with later targets including traumatic brain injury (TBI) and Alzheimer’s/dementia.